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Brown Norway rats immunized with renal tubular antigens in adjuvant develop 
a severe interstitial nephritis (1-3). The expression of disease is characterized by 
the  appearance  of anti-tubular  basement  membrane  antibodies  (aTBM-Ab) 1 
followed by an intense mononuclear cell infiltrate. The cellular lesion is composed 
of several  subsets  of T  lymphocytes, macrophages,  and  Ig  + cells  (4).  Natural 
killer  cells  have  also  been  observed  in  the  murine  form  of disease  (5).  The 
relevant tubular antigen for disease is a glycoprotein expressed on cortical tubular 
basement membranes (Neilson and Kefalides, unpublished observations) by genes 
closely linked with albinism on the first linkage group (1).  The most important 
immunologic response  to  this  tubular  antigen  is cell  mediated, and  is  largely 
determined by an RT 1-1inked gene. There are strain differences in the amount 
of aTBM-Ab  produced,  but the  genes involved are  not  RT1  linked and  the 
antibody titer seems to have little or no effect on disease susceptibility (1). 
If rats are pretreated with tubular antigen-reactive T  lymphoblasts in adjuvant 
and then immunized to produce disease, they do not develop interstitial lesions 
(6). Protected animals show a decreased T  cell proliferative response to tubular 
antigens, produce aTBM-Ab with a reduced binding affinity for tubular antigen, 
and develop antiidiotypic antibodies that bind to idiotypes within the antigen- 
binding variable  region  of monoclonal o~TBM-Ab.  These  results  suggest that 
antiidiotypic immunity might have a modulating influence in this model both at 
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the  level  of antigen  recognition  and  in  the  development  of antigen-receptor 
heterogeneity. 
In the present studies we have further observed that rats normally immunized 
to produce disease do not make a humoral or cell-mediated antiidiotypic immune 
response  to ocTBM-Ab.  Antiidiotypic immunity can be generated,  however,  if 
the rats are pretreated  with low-dose cyclophosphamide before immunization. 
Because  nephritic  rats  also  develop  nonspecific  suppressor  cells  early  in  the 
aTBM immune response, we evaluated the effects of this suppressor system on 
the generation of antiidiotypic immunity. We now report that a  cyclophospha- 
mide-sensitive, RT7.1 +, OX8- suppressor T  cell inhibits the formation of such 
an  antiidiotypic effect.  Furthermore,  tubular  antigen-reactive  cells  unencum- 
bered by this suppression can induce a protective antiidiotypic immune response 
in naive animals. These findings suggest that suppressor T  cells in the afferent 
phase of this nephritogenic immune response can modulate subsequent immu- 
noregulatory events. 
Materials and Methods 
Animals.  Brown Norway rats obtained from the Charles River Breeding Laboratories, 
Wilmington, MA were maintained by the Department of Laboratory and Animal Medi- 
cine, University of Pennsylvania School of Medicine. 
Preparation of Renal Tubular Antigen.  Rabbit renal tubular basement membrane anti- 
gens (RTA) and rabbit liver segment membrane antigens were isolated by a differential 
seiving technique (7). Highly enriched basement membrane fragments were sonicated, 
lyophilized, and stored at -70 °  C. Soluble renal tubular antigens (SRTA) and soluble liver 
antigen (SLA) were made from these lyophilized membranes using collagenase digestion 
(1, 8). 
Induction of Disease.  Groups of rats were immunized with 2 mg of RTA in complete 
Freund's adjuvant (CFA)  by footpad and/or  subcutaneous injections (1,  6).  Control 
animals received CFA alone. Some rats were pretreated with 50 mg/kg of cyclophospha- 
mide 48-72 h before their immunization (9). 
Assessment of In Vitro Lymphocyte Proliferation.  Cells from draining lymph nodes were 
placed in suspension in RPMI  1640 supplemented with antibiotics, L-glutamine (2 raM), 
N-2-hydroxyethylpiperazine-N'-2-ethane-sulfonic acid (10 mM), 2-mercaptoethanoi (5 x 
10  -2 m M), and 5 % heat-inactivated fetal calf serum (I). 2 x  105 cells in 0.2 ml of complete 
media were co-cultured in triplicate microtiter wells at 37°C in 5% CO2 in the presence 
or absence of concanavalin A (Con A) (2.5-10 #g/ml), SRTA (5/~g/ml), SLA (5 #g/ml), 
or purified protein derivative (PPD) (10 •g/ml).  Cultures were labeled with [SH]thymidine 
([3H]TdR)  during the last 4 h before harvesting for scintillation counting. The Con A 
cultures were harvested on day 3 and all other cultures were harvested on day 4. The 
ratio of mean cpm from stimulated cultures per mean cpm from control cultures was used 
to calculate a stimulation index _  SEM. 
Assessment of In Vitro Suppressor Cell Activity.  The mitogen-stimulated suppressor cell 
assay has been previously described in detail (7). Briefly, 1.25 × 105 irradiated (3,000 rad) 
immune or control lymphocytes were co-cultured (1:1 ratio) with third-party lymphocytes 
from normal animals used as responder cells. Con A was added to those wells designated 
for stimulation and media was added to control wells.  Cultures grown in  flat-bottom 
microtiter plates for 72 h at 37°C were assayed for blastogenesis  by adding [SH]TdR. The 
results were expressed as a stimulation index or as a percent suppression using a previously 
described formula (7). 
Preparation of T  Cells and Their Subpopulations.  Cell suspensions  were depleted of T 
lymphocytes with a monoclonal IgM and anti-RT7.1 antibody (from BC84.5 hybridoma 
[ 10-12] provided by Dr. John Ely and Dr. Frank Fitch, University of Chicago, Chicago, 
IL) and a mixture of rabbit and guinea pig complement. By microcytotoxicity assay, this NEILSON  ET AL.  1011 
antibody kills 95% of thymocytes, 58-62% of lymph node cells, and 33-35% spleen cells. 
Nylon wool T  (NWT) and nylon wool adherent (NWA) cells were obtained from packed 
nylon wool columns (3-4 x  108 cells added to a 35-ml column) according to the methods 
of Julius et al.  (13).  Monoclonal antibody OX8 (cytotoxic/suppressor T  cell subset) was 
purchased from Accurate Chemical & Scientific Corp., Westbury, NY (14). The OX8 
monoclonal antibody was used to enrich for suppressor T  cells by an indirect panning 
technique (15,  16).  Briefly, 2.5  ml  of affinity-purified rabbit anti-mouse  IgG (Zymed 
Laboratories, San Francisco, CA) in a concentration of 1 mg/ml in phosphate-buffered 
saline (PBS) was incubated on 60 x  15-mm polystyrene dishes overnight at 4°C. After 
removal of the Ig solution, the plates were washed and blocked with 5% fetal calf serum 
in PBS (PBS-5) for 30 min. The fetal calf serum was then washed out before the addition 
of the T  cells.  25 x  106 NWT were preincubated in 0.2 ml of a  1:40 dilution of OX8 
antibody (ascites fluid) for 30 min at 40C. After extensively washing the cells in PBS, they 
were transferred onto the anti-IgG-coated dishes for 60 min at 22°C. Midway through 
the incubation the dishes were gently rocked. Nonadherent cells were removed from the 
plates with three cycles of swirling and washing with PBS-5. After the nonadherent cells 
were removed, 3 ml of chilled PBS-5 was added to the dishes, which were then placed at 
4°C for 30 min. The adherent cells were then resuspended by vigorous pipetting and 
further washed with chilled PBS-5. The presence of Ig  + cells in the separation mixture 
was determined by direct immunofluorescence using RITC-anti-rat Ig (gift of Dr. Susan 
Webb, Wistar Institute, Philadelphia) and the percentage of OX8  ÷ cells was determined 
by indirect fluorescence using FITC-anti-mouse IgG (Cappell Laboratories, West Chester, 
PA). 
Preparation of Idiotypes.  Monoclonal anti-tubular basement antibodies BN 52/19 (IgG 1) 
and BN48/12 (IgG2a) were derived from rat-mouse fusions as previously described (6). 
Purified preparations of these antibodies were made from cell cultures grown in serum- 
free media for 36 h. The media was cut with 50% ammonium sulfate and the pellet was 
resuspended in distilled water and extensively dialyzed against PBS. These preparations 
contained >90%  IgG by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Po- 
lymorphic idiotypes (RE-Id) were prepared by acid eluting aTBM-Ab  from nephritic 
kidneys using glycine-HC1 (pH 2.6) (17). The pH of the eluate was neutralized to pH 7.3 
and further cut with 50% ammonium sulfate. Affinity-purified eluate was prepared by 
passing the sulfate-precipitated antibodies over an affinity column made with anti-rat IgG 
coupled to activated Sepharose  4B  (Pharmacia  Fine  Chemicals,  Piscataway,  NJ)  (18). 
These polymorphic aTBM-Ab were then eluted from the affinity column with glycine- 
HCI (pH 2.6). 
Preparation of Antiidiotypic Antibodies.  Two antiidiotypic antibodies were independently 
prepared. TB-ald antibodies were derived from the serum of BN rats immunized with 
tubular antigen-reactive T  lymphoblasts as previously described (6). Low-titered aTBM- 
Ab were removed from this preparation by extensive adsorption with tubular basement 
membranes. RE-aid antibodies were prepared by immunizing a rabbit with polymorphic 
aTBM-Ab (RE-Id) that had been eluted from nephritic kidneys. This hyperimmune serum 
containing RE-aid antibodies was extensively absorbed against BN gammaglobulin cou- 
pled to activated Sepharose 4B (18).  The specificity of their binding was determined by 
competitive inhibition  radioimmunoassays  using  SRTA,  SLA,  relevant  idiotype,  and 
control antibodies. To determine the specificity of the TB-ald antisera, polyvinylchioride 
(PVC) plates coated overnight with 25 #! of the antisera at a dilution equal to 50% binding 
reactivity to RE-Id. After blocking with 4% bovine serum albumin (BSA), several potential 
inhibitors were coincubated at several dilutions for 2 h with ~SI-RE-Id. To determine the 
specificity of the  RE-aid  antisera,  RE-Id  was  coated  on  PVC  plates  overnight at  a 
concentration of 25 #g/ml. After blocking, RE-aid at 50% binding reactivity was then 
coincubated with several potential inhibitors for 3 h. After three washes,  this assay was 
developed with  l~I-affinity-purified anti-rabbit  IgG.  Individual wells  from both assays 
were cut from the PVC plates for counting and the results were expressed as a percent of 
maximum binding. 
Screening Assay for Antiidiotypic Antibodies.  This solid-phase screening assay for antiidi- 1012  ANTIIDIOTYPIC IMMUNITY  IN  INTERSTITIAL NEPHRITIS 
otypic antibodies has been previously described (6). Briefly, optimum concentrations of 
cold idiotype (either BN52/19 or RE-Id) in 0.02 M PO4 buffer were incubated overnight 
at 4°C in PVC plates. The plates were washed and blocked for 1 h with 4% BSA. Serial 
dilutions of pooled test antisera (25 ul) were then incubated at 22 °C for 3 h. After further 
washing,  12nI-idiotype was  added and  the  incubation continued for an additional  2  h. 
Individual wells were then counted and the results expressed as a percent of maximum 
binding. 
Preparation  ofldiotype-coupled  Cells.  Idiotypic antibodies were coupled to normal, syn- 
geneic spleen cells using a carbodiimide procedure as previously described (19).  Briefly, 
BN spleen cells were treated with Tris-buffered 0.83% ammonium chloride (pH 7.2) to 
lyse the erythrocytes. 4 x  108 cells were incubated with 1 mg of BN52/19 and 25 mg of 
1-ethyl 3-(3-diethylaminopropyl)carbodiimide  (EDCI) in 1 ml of 0.9% saline. The mixture 
was gently rotated at 4°C for 90 rain and then gently washed three times with normal 
saline.  Using these conditions, ~ 19.4/~g of BN52/19 (trace labeled with ~5I) was bound 
to 5 x  107 viable cells. In some experiments, horse gamma globulin (HGG) was also linked 
to normal spleen cells. Cell viability at the end of this coupling procedure averaged ~80% 
by trypan blue exclusion. 
Induction  and Elicitation  of a Delayed-type Hypersensitivity (DTH) Response to Idiotype and 
Tubular Antigen.  DTH responses to BN52/19 or HGG were induced by subcutaneously 
immunizing naive rats with 2.5 x  107 BN52/19- or HGG-coupled spleen cells in each 
flank (19). DTH responses to RTA were induced by subcutaneously immunizing rats with 
RTA in CFA (20). Five to six days after such immunizations, groups of  rats were challenged 
in one footpad with 50 ~g of soluble antigen (either BN52/19, RE-Id, BN48/12, control 
Ig, HGG, SRTA, and SLA, depending on the experiment) in 50 t~l of PBS. Swelling as 
an index of DTH was measured 24 h later using a spring-loaded engineer's micrometer 
(Schlesingers for Tools Ltd., Brooklyn, NY). The magnitude of swelling was expressed as 
the increment between the challenged footpad compared with an  unchallenged (or in 
most cases PBS challenged) footpad in inches x  10  -3. All measurements were cage-blind. 
In selected experiments, histologic sections of swollen footpads revealed mononuclear cell 
infiltrates typical of DTH reactions. 
Adoptive  Transfer  Experiments.  Draining  lymph  node  cells,  spleen  cells,  or  pooled 
mixtures were harvested 5-22 d after various immunization protocols. Single-cell suspen- 
sions  were washed,  counted, and intravenously injected (1.2-10  x  107 ceils/rat) using 
PBS as the vehicle. In some experiments, these cells were separated into various subpop- 
ulations (NWT,  NWA,  NWT/OX8-,  NWT/OX8 ÷, and T  cell depleted with aRT7.1 
plus C'). 
Assessment of  Renal Disease.  Kidney tissue was prepared for light microscopy by standard 
methods for this laboratory (1). The degree of interstitial involvement was qualitatively 
graded from 0 to 4 on coded sections and expressed as a mean _+ SEM for each group. 
Statistical  Analysis.  Differences between  experimental  groups  were  determined  by 
Student's t test. 
Results 
Assessment of the Antiidiotypic hnmune Response in Nephritic Rats.  In an introduc- 
tory series of experiments, we wished to determine if rats normally immunized 
to produce disease  would also  demonstrate some  measure  of antiidiotypic  im- 
munity towards a  relevant spectrum of tubular antigen-reactive immune prod- 
ucts.  Two screening assays were developed to detect either a  humorai  or cell- 
mediated  antiidiotypic  immune  response.  The  most  convenient  and  isolable 
source of idiotype in this model is aTBM-Ab. We reasoned that aTBM-Ab eluted 
from nephritic  kidneys (RE-Id)  might  constitute an  important  source of poly- 
clonal and polymorphic idiotype because the eluate reflects a  relevant spectrum 
of tubular antigen-binding reactivity (21). In preparation for the serum-screening 
studies, two antiidiotypic antisera were independently prepared for use as positive NEILSON ET  AL.  101 3 
controls.  TB-ald  antibodies  were  made  by  hyperimmunizing  BN  rats  with 
syngeneic tubular antigen-reactive  T  lymphoblasts (6).  RE-aid antibodies were 
prepared  in a  rabbit hyperimmunized  with  RE-Id.  Neither of the antiidiotypic 
antibodies bound normal IgG or SRTA by radioimmunoassay, nor did they stain 
tubular basement membranes by indirect immunofluorescence (data not shown). 
In Fig.  1  A, we observed in specificity studies that RE-aid antisera was specifically 
inhibited  by RE-Id antibodies,  and by SRTA.  Quite similar findings were also 
observed in the specificity studies for TB-aId antibodies (Fig. 1 B). These findings 
by competitive inhibition  criteria  suggest that  both antiidiotypic antisera  were 
primarily  directed  towards  idiotypes  in  or  near  the  antigen-binding  region. 
Furthermore, in Fig.  1 C, low dilutions of TB-aId antisera significantly inhibited 
the binding of RE-aid to RE-Id when compared with control sera from nephritic 
rats that  had been adsorbed to remove aTBM-Ab. This  latter inhibition  study 
suggests that the tubular antigen-reactive T  and B cell repertoires possibly share 
some  serologically  detectable  determinants  that  may  be  idiotypes.  We  have 
previously reported (6), in addition to the present studies, that TB-aId antisera 
binds monoclonal aTBM-Ab BN52/19 in or near its antigen-binding region. By 
competitive  inhibition  radioimmunoassay,  BN52/19  represents  ~13%  and 
BN48/12 3-4% of the maximum inhibitable binding reactivity expressed by RE- 
Id for RE-aid (data not shown). 
In  direct-binding  screening  experiments,  the  sera  from  nephritic  rats  were 
examined for the presence of antiidiotypic antibodies against aTBM-Ab. In Fig. 
2, nephritic  sera were analyzed over a  100-d interval.  No binding to BN52/19 
(Fig.  2A)  or to  RE-Id  (Fig.  2B) was observed  with  these pooled interval  sera 
compared with the positive controls. Interestingly enough, however, antiidiotypic 
binding could be demonstrated on day 28 if rats were pretreated with low-dose 
cyclophosphamide  before their  immunization  with  RTA/CFA.  Although  the 
data is presented as pooled sera, individual  sera from three cyclophosphamide- 
pretreated  rats also exhibited similar binding  reactivity.  If the pooled antisera 
was  absorbed  against  an  anti-rat  IgG  column,  its  binding  to  BN52/19  was 
reduced  to  control  values,  suggesting  that  the  positive binding  effect was not 
due to excess antigen  in that particular  sera (data not shown).  Furthermore,  if 
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FIGURE 1.  Specificity  and cross-reactions of antiidiotypic antisera. (A) The specificity  of RE- 
aid antibodies was demonstrated by competitive inhibition studies using SRTA (I-I), SLA (.), 
RE-Id (O), and control IgG (0). The findings demonstrate that RE-aid antibodies  are inhibited 
from binding to RE-Id in the antigen-binding region; (B) TB-aId antisera was also specifically 
inhibited from binding to RE-Id, in a similar fashion; (C) TB-ald antisera (A) in low dilutions 
inhibited the binding of RE-aid to RE-Id when compared with control sera from nephritic 
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FIGURE 2.  Direct-binding screening assay for antiidiotypic  reactivity. (A) Pooled interval sera 
from five to seven rats per group with interstitial nephritis were tested for binding reactivity 
to monoclonal aTBM-Ab BN52/I 9.  None of the interval sera showed any reactivity when 
compared with positive control sera (TB-aId). However, binding was demonstrated with sera 
taken from nephritic rats pretreated with cyclophosphamide; (B) Interval sera were also tested 
for binding to RE-Id. Antiidiotypic reactivity was only observed in the positive control (RE- 
aid) and in sera obtained from nephritic rats pretreated with cyclophosphamide. 
TABLE  I 
DTH Response to Polymorphic aTBM-Ab Idiotypes and to Tubular Antigen 
DTH Response* 
Immunization  Control  Hist°l°gy  0 
RE-Id  SRTA  SLA  IgG 
RTA/CFA  3.0±0.3  2.8±0.3  24.3±2.41  3.1±0.2  2.0±0.3 
CTX-RTA/CFA  $  15.5±0.81  3.0±0.3  24.7±2.21  3.4±0.3  3.2±0.41 
CFA  2.3±0.3  2.8±0.2  3.8±0.4  3.3±0.5  0.0±0.0 
--  3.0±0.2  3.5±0.4  3.8±0.5  3.2±0.2  -- 
* Data points from 6 to 11  rats per measurement were calculated as a mean footpad increment in 
inches times 10 -s ± SEM, 22 d after immunization, 24 h after challenge. 
* 50 mg/kg of cyclophosphamide (CTX) was administered 3 d before immunization. 
Severity of the interstitial lesions was qualitatively graded from 0 to 4 and expressed as a mean ± 
SEM. 
! P < 0.001  compared with unimmunized controls. 
P < 0.04 compared with RTA/CFA group. 
the plate-coated BN52/19  was replaced by control IgG, binding was also reduced 
by 90 %. This latter finding suggests that the positive result observed with antisera 
from cyclophosphamide-pretreated  rats cannot be explained by the presence of 
rheumatoid  factors. 
We also examined the possibility that an antiidiotypic immune  response to RE- 
Id might be more easily demonstrated  in nephritic rats as a cell-mediated reaction. 
In  Table  I,  two  groups  of  rats  were  subcutaneously  immunized  to  produce 
disease.  At  22  d,  they  were  footpad  challenged  with  tubular  antigen  (SRTA), 
polymorphic  idiotype (RE-Id), or with  specificity controls.  The  findings in  this NEILSON  ET  AL.  1015 
TABLE  II 
Transfer of DTH to Polymorphic aTBM-Ab Idiotypes 
Donor cells*  n  Treatment 
DTH response* 
RE-Id  Control IgG 
CTX-RTA/CFA  0  6  --  17.1 +  0.5 n  3.8 4- 0.3 
CTX-RTA/CFA  4  C'  16.3 4- 0.6 n  4.3 4-_ 0.3 
CTX-RTA/CFA  4  aRT7.1  +  C'  6.3 4- 0.5  4.0 +  0.4 
CTX Control  5  --  4.2 4- 0.4  5.0 4- 0.5 
Control  5  --  3.8 4- 0.6  3.8 _+ 0.6 
--  5  --  3.3 4- 0.4  3.6 4- 0.4 
* Donor lymph node cells harvested from rats 21  d  after immunization were transferred into naive 
recipients. 
* Recipients were challenged 4-6 h  after transfer and the mean footpad increment in inches times 
10  -5 _+ SEM was determined 24 h  later. 
0 50 mg/kg  of cyclophosphamide (CTX)  was administered 3  d  before the immunization of donor 
animals. 
! P  <  0.001  compared with unimmunized controls. 
table suggest that rats immunized with RTA/CFA make a specific DTH reaction 
to tubular antigen, but not to REd& Similar findings were observed at days 32 
and 43 (data not shown). If, however, immunized animals were pretreated with 
low-dose cyclophosphamide, such a DTH reaction to polymorphic idiotype could 
be observed. As shown in Table  II, this DTH effect to RE-Id was specifically 
transferred to naive rats with immune lymph node cells from cyclophosphamide- 
pretreated donors. When these donor cells were treated with anti-T cell antibod- 
ies (anti-RT7.1) and complement, however, this antiidiotypic reaction did not 
occur, suggesting the DTH reaction was T  cell mediated. It was also of interest 
to observe in Table I that rats pretreated with low-dose cyclophosphamide, the 
same rats who made an antiidiotypic response to RE-Id, developed worse disease 
than rats immunized in a normal fashion (P <  0.04). This finding is consistent 
with the elimination of a cyclophosphamide-sensitive suppressor cell mechanism 
in  rats with evolving nephritic lesions (9).  A  detectable antiidiotypic immune 
response to RE-Id in the setting of worse disease is also compatible with the view 
that a widespread loss of cyclophosphamide-sensitive suppressor function might 
obviate any subsequent suppressive antiidiotypic effect on disease. 
Development of  Suppressor  T  Cells Early  in  the  Nephritogenic Immune  Re- 
sponse.  Rats normally immunized to produce disease also develop suppressor T 
cells during the afferent phase  of the nephritogenic immune response (1),  an 
effect not unlike that which we have previously observed in nephritic guinea pigs 
(7).  Because rats with nephritis do not seem to make an antiidiotypic immune 
response unless they are pretreated with low-dose cyclophosphamide, we wished 
to determine if this suppressor cell effect might influence the development of 
antiidiotypic immunity. Before this question could be directly examined, how- 
ever, we wanted to further characterize this suppressor cell system. In Fig. 3A, 
it can be observed that the lymphocyte proliferative response to Con A and PPD 
in nephritic rats, expressed as a percent of control, is maximally reduced ~2 wk 
after immunization.  Over the same time period,  the tubular  antigen-reactive 
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FIGURE 3.  Interval comparisons of lymphocyte proliferative responses from nephritic and 
control rats to antigens and mitogens. (A) The blastogenic response to PPD ((3) and Con A (0) 
of lymphocytes from nephritic rats expressed as a percent of control was suppressed as early 
as 9 d after immunization (four to six rats per group). The suppression was persistent for at 
least another 10-12 d. (I) compares the Con A response of CFA-immunized rats to normal; 
(B) In spite of the ongoing suppression, nephritic rats showed a strong proliferative response 
to SRTA (&) compared with controls (El). The response of nephritic rats is tubular antigen- 
specific, as they did not respond to SLA (A). 
TABLE  III 
A Representative Experiment Illustrating the Blastogenic Response to Antigens and Mitogens 
Group*  Stimulant 
[3H]TdR incorporation* 
Con A  PPD  SRTA  SLA 
RTA/CFA  _+  9,727567 (17.1)~  7,448992  (7.5)  17,825992  (17.9)  1,190992  (1.2) 
CFA  +  45,969 (71.3)  22,399 (26.0)  980  (1.1)  667 (0.8) 
-  645  861  861  861 
* Pooled lymph node cells from three animals per group harvested 14 d after immunization and 
cultured in  the presence of mitogen or antigen as described in  Material and  Methods.  Con A 
cultures harvested at 72 h; antigen cultures harvested at 96 h. 
* Mean cpm for replicate cultures. 
J Stimulation index. 
3  wk  when  compared  with  controls  (Fig.  3B).  The  response  to tubular  antigen 
(SRTA) is specific as there is virtually no response to liver antigen (SLA) controls. 
The  tabulated results of a  representative  experiment  done with lymph node cells 
on  day  14 can  be seen  in  Table  III. As illustrated  in  this  experiment,  both  the 
PPD  and  Con  A  responses  were  markedly  lower  in  the  immune  rats  receiving 
RTA/CFA  compared  with an appropriate  control. 
We attempted  to identify the cells responsible  for this suppressive effect using 
a Con A-driven suppressor cell assay. In this assay, the ability of neutral responder 
ceils  to  proliferate  in  the  presence  of Con  A  and  irradiated  lymph  node  cells 
from  either  nephritic  or  control  animals  can  be  compared  and  expressed  as  a 
percent  suppression  (7).  In  Table  IV,  the  characterization  of these  suppressor 
cells was examined  at several different  doses of Con A. The  findings at all three 
doses of Con  A  were remarkably  similar,  although  the magnitude  of the stimu- 
lation  indices  did  vary with  the  amount  of mitogen.  The  findings  in  this  table NEILSON  ET  AL. 
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Con A-stimulated Suppressor Cell Assay 
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Con A-induced stimulation index of neutral responder cells* 
Admixed cells* 
10 ~g/ml  10 ~ag/ml  5 tAg/ml  5 t~g/ml  2.5 pg/ml 
RTA/CFA  6.3 ± 0.7 (96.8)!  58.8 4- 6.6 (31.4)  84.7 4- 9.5 (68.3)  141.9 ±  7.0 (56.4)  50.5.1 ±  10.3  (66.3) 
RTA/CFA (TD)  72.4 4- 5.6 (4.3)  283.1  4- 12.4 (4.0)  1,26fi.3  + 48.5 (0.1) 
CTX-RTA/CFA  142.7 4- 1.5 (27.6)  198.4 4- 15.7  (25.8) 
Control (C')  75.7 4- 5.9  294.9 "4- 34.0  1,274.9 4- 85.7 
Control  197.1  ±  44.6  85.1  ±  11.6  267.6 4- 11.9  326.1  ±  38.0  1,388.1  -4- 166.1 
* The admixed  lymph node cells were  harvested from  rats  14 d  after immunization. These  cells were 
treated with 3,000 rad before their use. TD, T cell depletion with anti-RT7.1 antibodies plus complement; 
C', cells treated with complement alone; CTX-RTA/CFA,  donor animals were pretreated with cyclo- 
phosphamide before receiving RTA/CFA. 
* The admixture of neutral responder and irradiated cells was cultured at a  1 : 1 ratio in various concentra- 
tions of Con A for 72 h. Data is expressed as mean stimulation index __. SEM. 
0 Numbers in parentheses equal the percent suppression compared with control. 
suggest that immune lymph node cells harvested from RTA/CFA rats on day 
14  markedly suppressed the Con A  response of neutral responder ceils.  This 
suppression was not nearly as evident if the RTA/CFA co-cultured cells were 
from cyclophosphamide-pretreated donors, suggesting the suppressor cell was 
sensitive  to  cyclophosphamide.  The  suppression  observed  in  the  presence of 
irradiated lymph node cells from nephritic rats was also abrogated when these 
cells were pretreated with anti-RT7.1  antibodies and  complement. From  the 
data collected in these experiments it would seem that, in addition to developing 
disease, nephritic rats also develop a nonspecific suppression that occurs early in 
the immune response, is T  cell mediated, and cyclophosphamide sensitive. 
Ef~ct  of  Nonspecific  Suppression  on  the  Development  of  Antiidiotypic  Immu- 
nit),.  Because nephritic  rats  do  not  normally make an  antiidiotypic immune 
response towards polymorphic aTBM-Ab, we wished to assess the potential effect 
of this nonspecific suppression  on the development of antiidiotypic immunity. 
To perform these experiments, we took advantage of methods that allow the 
measurement of DTH responses to idiotype using a  footpad assay (19).  In our 
experiments, naive rats were subcutaneously immunized with idiotype expressed 
on monoclonal aTBM-Ab BN52/19-coated spleen cells. The immunized animals 
were challenged 5-6 d  later with 50 ug of BN52/19  in PBS.  The other hind 
footpad  was  usually injected with  PBS alone, although  injecting with  PBS  or 
leaving the footpad uninjected did not seem to make very much difference. In 
Fig.  4,  rats  immunized  with  BN52/19-coated  spleen  cells,  who  were  then 
challenged with BN52/19,  developed significant, incremental footpad swelling 
when compared with animals not immunized but challenged with the same dose 
of BN52/19.  The fine specificity of this  DTH  reaction was demonstrated by 
immunization with control cells (EDCI alone), or by challenge with purified IgG 
or  BN48/12  monoclonal  aTBM-Ab,  which  also  did  not  induce  significant 
footpad  swelling.  Rats  were  also  injected  with  HGG-coated  spleen  cells  to 
establish the fact that the response to BN52/19 was not unique to this antibody. 
Rats immunized with HGG-coated spleen cells made a significant DTH response 
to HGG compared with control, but similarly immunized animals did not respond 
when challenged with BN52/19.  In Table V,  we also observed that the DTH ] 018  ANTIIDIOTYPIC  IMMUNITY  IN  INTERSTITIAL  NEPHRITIS 
Immunization  Challenge  Footpad Increment  (meon d: SEM) 
i 
BN52/19- SPC  BN52/19  I P<O.O08 
Control- SPC  BN52/19  II-I  NS 
BN52/19-SPC  Control  "l'gG  BJ'I  NS 
BN52/19-SPC  BN48/12  ~  NS 
HGG-SPC  BN52/i9  el  NS 
HGG*SPC  HGG  i  P< 0.001 
BN 52/19 -SPC  HGG  ~  N S 
BN52/19 
HGG  J 
i  i  i  [  i 
0  5  I0  15  20 
I0  "3 Inches 
FIGURE 4.  DTH  response to idiotypes expressed on BN52/19.  Rats were subcutaneously 
immunized with monoclonal aTBM-Ab BN52/19-coated spleen cells (SPC). 5-6 d  later, one 
footpad  was  challenged with  BN52/19,  and  a  significant increment in  swelling occurred 
compared with the PBS-challenged control footpad. If rats were immunized with control cells 
(EDCI-treated) and challenged with BN52/19, no response was demonstrated. The reaction 
was  specific for  idiotype because  rats immunized with  BN52/19-SPC  did not respond to 
control  IgG,  BN48/12,  or  HGG.  If the immunization was  done  with HGG-spleen cell,  a 
specific response could also be demonstrated to HGG (four to six rats per group were used). 
TABLE  V 
Transfer of DTH to Monoclonal aTBM-Ab 
Donor cells*  n  Treatment  BN52/19 DTH 
response* 
BN52/19 immune  4  --  15.0 :t: 0.8  i 
BN52/19 immune  7  C'  13.4 -+ 0.9  t 
BN52/19 immune  4  aRT7.1  +  C'  2.8 +  1.8 
Control  5  --  4.4 +  0.5 
--  4  --  3.8  +  0.5 
* Donor lymph node cells harvested from rats  5  d  after immunization 
with BN 52/19-coated spleen cells were transferred into naive recipients. 
* Recipients were challenged 4-6 h  after transfer and the mean footpad 
increment in inches times 10  -3 +  SEM was determined 24 h later. 
g P <  0.001 compared with unimmunized controls. 
response to BN52/19 could be adoptively transferred to a naive rat with BN 52/ 
19-reactive cells. Such a transfer, however, was inhibited if the donor cells were 
pretreated with anti-RT7.1 antibody and complement, suggesting that the DTH 
response to BN 52/19 was T cell mediated. Selected footpads were also evaluated 
histologically, and were found to contain mononuclear infiltrates, particularly 
around blood vessels (data not shown). 
With  this  footpad  assay,  we  then  examined  the  influence  of transferred 
lymphocytes from nephritic rats on the development of antiidiotypic immunity 
to BN52/19.  In Fig. 5 (group I), it can be observed that lymph node or spleen 
cells from nephritic rats could markedly inhibit the development of antiidiotypic 
immunity when they were transferred into naive animals at the time of their 
immunization with BN52/19-coated spleen cells. This suppressive effect could 
be  abolished by  T  cell  depletion,  as  well as when the transferred cells  were 
harvested from cyclophosphamide-pretreated donors. Furthermore, lymph node 
or  spleen  suppressor  cells could attenuate a  similar  DTH  response  to  HGG- 
coated spleen cells (See Fig. 5; group II). In Table VI, the suppressive effect of 
NWT cells from nephritic rats was compared with the effect of NWA cells. By 
indirect fluorescence, the NWT population from lymph nodes contained <5% Group 
I 
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Immunizotion  Ceils R~eived  Chollenge  Footpod Increment ( meon -4- SEM ) 
I 
BN52/19-SPC  -  BN52/19  m  P  0.002 
BN52/19-SPC  RTA immune LNC  BN52/19  ~  NS 
BN52/FJ-SPC  Control  LNC  BN52/19  I  P<O.O01 
BN52/I9-SPC  RTA immune SPC(C e)  BN52/19  ~  NS 
BN52/19-SPC  RTA immune SPC(TD)  BN52/I9  ~  P  <O001 
BN52/19-SPC  CTX-RTA immune  SPC  BN 52/19  IP<O.OOl 
BN52/19-SPC  Control SPC  BN52119  I  P  <0.001 
-  -  BN 52/19  BE4 
TI  HGG- SPC  -  HGG  P  <o.0o! 
HGG- SPC  RTA immune LNC  HGG  mini  NS 
HGG- SPC  Control  LNC  HGG  P  <ODOI 
HGG- SPC  RTA immune  SPC  HGG  ~  NS 
HGG- SPC  Control  SPC  HGG  P  <0.002 
-  -  HGG  BB-I 
I  , 
o  5  ,;  ,;  2'0 
lot3 Inches 
FIGURE 5.  Assessment of a suppressor T  cell effect from nephritic rats on the development 
of antiidiotypic immunity. In group I, all rats (four to eight rats per group) were immunized 
with  BN52/19-SPC  (SPC,  spleen  cells;  LNC,  lymph  node  cell).  Other  lymphocytes from 
nephritic or control rats were intravenously administered at the time of immunization. 5-6 d 
later each group was  challenged with BN52/19.  Immune spleen or lymph node cells from 
nephritic rats prevented the development of an antiidiotypic immune response. Such inhibition 
was  averted if the lymphocytes were T  cell-depleted (TD) before transfer,  or if they were 
derived from cyclophosphamide (CTX)-pretreated donors.  In group II, suppression was also 
provided by lymphocytes from nephritic rats such that a DTH response was not made to HGG. 
This latter finding suggests that the overall suppressive effect was nonspecific. 
TABLE  VI 
Suppression of Antiidiotypic Immunity with OX8- T Lymphocytes 
Immunization*  n  Cells transferred*  Cell dose  BN52/19 DTH re- 
sponse  ! 
BN52/19-SPC  5  --  --  17,0 3= 0.4 m 
BN52/19-SPC  4  RTA/CFA  5 x  107  7,0 3= 0.7 
BN52/19-SPC  3  RTA/CFA (NWT)  5 x  107  6.3 3= 0.8 
BN52/19-SPC  3  RTA/CFA (NWA)  5 x  107  15.5 3= 0.5 m 
BN52/19-SPC  5  RTA/CFA (OX8-)  1.2 x  l0 T  6.2 3= 0.4 
BN52/19-SPC  4  RTA/CFA (OX8 ÷)  1.2 x  107  14.8 3= 0.9 I 
BN52/19-SPC  4  CFA  5 ×  107  15.5 3= 0.5 I 
--  4  --  --  3.8  3=  0.5 
* Rats received 5 X 107 derivatized cells subcutaneously. SPC, spleen cells. 
* At the time of immunization, groups of rats also received pooled spleen/lymph node cells: RTA/ 
CFA and CFA cells were harvested from other rats 14 d after immunization; OX8-, NWT that do 
not bind OX8 antibodies; OX8 ÷, NWT that bind OX8 antibodies. 
0 Recipients were  challenged  with  BN52/19  at  5  d  after  immunization  and  the  mean  footpad 
increment in inches 3= SEM was determined 24 h later. 
! P <  0.001  compared with unimmunized controls. 
Ig  ÷  cells.  Of  these  T  cells,  ~15-17%  were  OX8 +.  These  NWT  were  further 
separated  into OX8-  or OX8 + subpopulations  by an indirect  panning  technique. 
After  separation  on panning  dishes,  the nonadherent  cells were  93%  OX8-  and 
the adherent  cells were  86%  OX8 +. The  results shown  in Table  VI suggest that 1020  ANTIID1OTYPIC  IMMUNITY  IN  INTERSTITIAL  NEPHRITIS 
the suppressive effect in the lymph nodes of nephritic rats is T  cell mediated by 
an  OX8-  cell.  Interestingly,  the effect was  not  demonstrated by  OX8 ÷ cells 
alone. 
Inhibition of Disease by the Adoptive Transfer of  Nonspec~c Suppressor Cells or by the 
Transfer of Idiotype-reactive Cells.  The studies performed thus far demonstrate 
that rats normally immunized to produce disease do not develop an antiidiotypic 
immune response  towards  idiotypes expressed  on  aTBM-Ab.  The  failure  to 
express this antiidiotypic immunity may be partly due to the concomitant devel- 
opment  of an  RT7.1 ÷,  OX8-  suppressor  T  cell.  If rats  are pretreated  with 
cyclophosphamide, however, this suppressor T cell does not appear, antiidiotypic 
immunity can be demonstrated, and disease is much worse (see Table I).  The 
reason that disease is much worse in cyclophosphamide-pretreated rats may be 
related to the fact that low-dose cyclophosphamide not only removes the nonspe- 
cific suppressor cell, but also removes the suppressive limb of the antiidiotypic 
immune response.  We  were  interested  to  know  what  the effects of such  an 
antiidiotypic  immunity  might  be,  were  it  allowed  to  develop.  To  test  these 
proposals  further,  we  adoptively  transferred  immune  cells,  with  or  without 
cyclophosphamide  pretreatment,  into  naive  recipients.  The  recipients  were 
rested for 5 d and then immunized with or without cyclophosphamide pretreat- 
ment. We reasoned that, in such a protocol, the transfer of idiotype-reactive cells 
(see Table I) unencumbered by nonspecific suppression might induce a suppres- 
sive antiidiotypic effect (22, 23). In Table VII, this hypothesis was tested using 
nine different experimental groups. It should be pointed out first, however, that 
immune  lymphocytes from  nephritic  rats,  under  a  variety  of experimental 
conditions, do  not  transfer disease when  they are intravenously injected into 
TABLE  VII 
Adoptive Transfer of  Antiidiotypic  Immunity 
DTH response  s  Renal 
Group  Donor cells*  Immunization  ~ 
SRTA  RE-Id  histology I 
1  --  RTA/CFA  22.5 +  0.6**  3.1  ±  0.4  1.8 _+ 0.2 
2  CTX-RTA/CFA  I  CTX-RTA/CFA  28.0 ___ 2.7**  16,0 ±  1.4"*  2.1  _  0.6 
3  CTX-RTA/CFA  RTA/CFA  7.5 +  0.7  ~  15.8 +  0.9**  0.1  ±  0,1 
4  CTX-RTA/CFA  CFA  14.3 ±  1.2"*  2,6 ±  0.3  0.0 ±  0,0 
5  RTA/CFA  RTA/CFA  8.0 ±  0.4  ~  3,5 ±  0.6  0.1  ±  0,1 
6  RTA/CFA  CFA  9.0 ±  1.5  ~  2.3 ±  0.6  0.0 ±  0.0 
7  CFA  RTA/CFA  21.5 ±  1.3"*  1.5 ±  0.5  1.0 ±  0.0 
8  CFA  CFA  2.6 ±  1.2  2.6 ±  0.3  0.0 +  0.0 
9  --  --  2.8 ±  0.3  2.5 ±  0.5  -- 
* Donor lymph node cells harvested from rats 14 d after immunization were transferred into naive 
recipients. 
* The recipients (three to four rats per group) were immunized as indicated  5  d  after these cell 
transfers. 
g Data points were calculated as a  mean footpad increment in inches times 10  -s +  SEM, 22 d after 
immunization, 24 h after challenge. 
I Severity of the interstitial lesions was qualitatively graded from 0 to 4 and expressed as a  mean __. 
SEM. 
50 mg/kg of cyclophosphamide (CTX) was administered 3 d  before immunization. 
** P <  0.001  compared with unimmunized controls. 
P <  0.05 compared with unimmunized controls. NEILSON  ET  AL.  1021 
naive recipients (24; Zakheim and Neilson, unpublished observations). Group 6 
confirms our previous experience that disease is not transferred with immune 
cells.  In group 5,  compared with group 7,  the immunization with RTA/CFA 
also did not induce disease after the transfer of immune lymphocytes. We have 
observed a similar finding in guinea pigs, and have attributed the lack of disease 
to the inhibitory influence of nonspecific suppressor T  cells in the transferred 
inoculum (Neilson et al., manuscript submitted). Furthermore, the rats in group 
5 made no DTH response to RE-Id, and only a mild one to SRTA. In contrast, 
when donor cells from cyclophosphamide-pretreated rats (group 3) were given 
to recipients who were then immunized with RTA/CFA, a  significant antiidi- 
otypic immune response was made to RE-Id. Only a very small response, however, 
was made to SRTA, and no disease was observed, suggesting that the transfer of 
RE-Id-reactive cells  before the  induction  of disease  could  suppress  the  later 
development of lesions. In Table II, we demonstrated that the expression of this 
antiidiotypic effect is T  cell mediated. In Table VII (group 2),  however, if the 
recipients receiving the same cells as group 3 were treated with cyclophosphamide 
before their immunization with RTA/CFA, the antiidiotypic immune response 
appeared, but so did disease.  These findings also suggest that low-dose cyclo- 
phosphamide may impair the suppressive phase of antiidiotypic immunity. Com- 
paring group 4  with groups 2 and 3, it is furthermore evident that the antiidi- 
otypic immune response  to  RE-Id  is  only demonstrable if the  recipients are 
immunized with RTA/CFA.  Finally, we would propose without formal proof, 
that the greater intensity of disease in group  1 compared with group 7  might 
reflect a  reduced effect of the adjuvant in rats receiving CFA-reactive cells, a 
condition that is equally shared by all experimental groups except group 1. 
Discussion 
The present studies illustrate several interesting findings related to the anti- 
idiotypic immune response in experimental interstitial nephritis. One unexpected 
observation made during the initial preparation of the positive control antiidi- 
otypic antibodies  was that  some degree of serologic cross-reactivity could be 
demonstrated between  TB-ald  and  RE-aid  antisera.  This  finding,  however, 
must be qualified on at least two counts. First, the observation was made with 
polymorphic antisera that possibly contained other unknown cross-reactivities. 
Second, the specificities of the antiidiotypic antibodies, during their derivation, 
were vulnerable to the potential source impurity of the idiotypes in question. It 
should  be  pointed  out,  however,  that  while  the  preparation  of the  TB-ald 
antisera could have been contaminated by a small number of B cells, it is unlikely 
that the preparation of the RE-aid antisera was contaminated by the presence 
of T  lymphocytes. Preliminary experiments furthermore suggest that  RE-aid 
antibodies selectively bind highly purified T  cells from immune rats with inter- 
stitial  nephritis  (data  not  shown).  Thus,  despite  the above  qualifications,  the 
observed cross-reactivity suggest there might be shared idiotypic determinants 
between  the  T  and  B  cell  repertoires  producing  aTBM  disease,  a  finding 
supported by previous studies in other experimental systems (25, 26). 
One  of  the  principle  aims  of  the  present  experiments,  however,  was  to 
determine if rats normally immunized to produce disease made any regulatory 1022  ANTIIDIOTYPIC  IMMUNITY  IN  INTERSTITIAL  NEPHRITIS 
or protective antiidiotypic immune response. Previous experiments suggest that 
rats pretreated with antigen-reactive T  lymphoblasts (6) or RE-aid antisera (27) 
do not develop aTBM disease because of an antiidiotypic effect. RE-aid antisera 
can also block the development of interstitial nephritis in guinea pigs (28).  In 
screening radioimmunoassays using RE-Id and BN52/19, we were nevertheless 
unable to demonstrate any binding reactivity to these antibodies using interval 
sera from rats with nephritis. Nor could any cell-mediated antiidiotypic immune 
response be demonstrated using a measured DTH reaction to RE-Id. The failure 
to observe a regulatory antiidiotypic effect is also consistent with our unpublished 
observation that aTBM-Ab titers to collagenase-solubilized tubular antigen peak 
around day 32,  but do not appreciably fall over an ensuring interval of 68  d. 
Interestingly enough, however, both a  humoral and cell-mediated antiidiotypic 
immune response could be observed if the rats were pretreated with low-dose 
cyclophosphamide before immunization. Furthermore, the cell-mediated antiidi- 
otypic response could be adoptively transferred by T  lymphocytes. 
The fnding that an antiidiotypic immune response appeared after pretreat- 
ment with cyclophosphamide provided an opportunity to both determine the 
effect of this antiidiotypic immunity on the expression of disease, and to char- 
acterize the suppressor mechanism that normally inhibits its development. From 
the information contained in the present studies, it seems that shortly after the 
induction  of disease,  a  cyclophosphamide-sensitive, nylon wool  nonadherent, 
RT7.1 ÷,  OX8-  suppressor  T  cell appears.  The  effect of this  suppressor  cell 
system is nonspecific; it can inhibit the proliferation of immune lymphocytes to 
mitogens or antigens, and can inhibit the development of  an antiidiotypic immune 
response to monoclonal aTBM-Ab.  While the appearance of the suppressor T 
cell system is tubular antigen dependent, it is not yet known whether the effect 
is  genetically restricted (29).  The comparative observation  that an  SRTA  re- 
sponse normally develops after immunization despite the subsequent generation 
of nonspecific suppression, whereas an antiidiotypic effect does not, is we believe, 
related to kinetic factors. That is, the latent development of nonspecific suppres- 
sor cells can only blunt, but not totally block an emerging SRTA response, while 
the operational presence of this suppression at the time of potential induction of 
an antiidiotypic effect, is completely inhibitory. The timing of this nonspecific 
suppression,  7-21  d  after  immunization,  furthermore seems to  permanently 
hamper the development of an antiidiotypic effect during the course of disease. 
The observation in adoptive transfer experiments that if suppression is present 
at  the  time  of immunization,  disease  does  not  occur  (Table  VII),  and  the 
observation that cyclophosphamide pretreatment of immune animals produces 
worse disease (Table  I), each suggest that this suppressor cell mechanism can 
directly influence both the induction and effector phase immune responses, a 
feature of some nonspecific suppressor systems (30). The use of low-dose cyclo- 
phosphamide has been associated with a selective depletion of suppressor T  cells 
in  mice  (31-33)  and  the  enhancement of experimental arthritis  in  rats  (9). 
Consistent with other studies (31), we did not observe any significant decrease 
in the aTBM-Ab antibody titers of nephritic rats that were pretreated with 50 
mg/kg of cyclophosphamide (data not shown). 
Nonspecific suppressor T  cells that have been studied in mice after immuni- NEILSON  ET  AL.  1023 
zation with antigens or haptens are reported to be cyclophosphamide sensitive 
and either Lyt  1,2,3 +  (34) or  Lyt  1+,2 -  (30)  cells.  Con A-induced nonspecific 
suppressor T  cells, conversely, seem to be Lyt 1-,2 + (35). The suppressor T  cell 
we have identifed in the present study in rats is OX8-,  not the classical OX8 + 
suppressor cell phenotype. Rather, it appears to be phenotypically similar to the 
suppressor cells described by Asano and Hodes (29,  30).  The nonspecific sup- 
pressor cells in their experiments were Lyt 1  +,2-, but required the participation 
of unprimed Lyt 2 + T  cells to complete the suppressive effect.  In our experi- 
ments, OX8 + T cells from nephritic rats, alone, could not inhibit the development 
of antiidiotypic immunity. We do not know as yet, however, whether OX8 + cells 
are required for the OX8- effect. While not formally established, the nonspecific 
suppressor T cell we have observed in the present experiments may also represent 
a subpopulation of suppressor-inducer cells (23, 36). Why nonspecific suppression 
should occur in this model of renal disease is not entirely clear. Its development 
precedes  a  deterioration  in  renal  function  so  that  the  nonspecific  effects  of 
uremia do not seem applicable. The supressive effect is also completely eliminated 
by T  cell depletion, and can be transferred with nylon wool T  cells, suggesting 
that an additional nonspecific macrophage effect is unlikely. The appearance of 
nonspecific T  cell suppression may reflect a feedback response to a broad variety 
of non- or peri-antigen-specific immune responses made early in the process of 
tubular antigen recognition (37). In support of this hypothesis, it has been known 
for many years that a large percentage of the immunoglobulin produced shortly 
after immunization is not specifc for the primary antigen (38). This background 
activity disappears after several weeks whereas specific antibody to the antigen 
remains  (39).  Such  nonspecific  activity  may  be  related  to  the  purity  of the 
antigen, its dose, or the strength of the adjuvant (40). It may also be the result 
of an  amplified  T  helper  cell  response  that  selects  the  relevant  isotypes and 
idiotypes that form the final effector repertoire (41, 42). 
The detection of an antiidiotypic immune response in the setting of worse 
disease (Table  I) after pretreatment  with cyclophosphamide is consistent with 
the view that a  widespread  loss of cyclophosphamide-sensitive suppressor cell 
function might limit or obviate any subsequent suppressive antiidiotypic effect 
on disease. To test this point further, we performed a series of adoptive transfer 
experiments (Table VII). In the design of these experiments, the cotransfer of 
contaminating CFA-reactive cells potentially reduced the overall magnitude of 
disease in all groups subsequently immunized with RTA in CFA. The presence 
of such cells probably induced an inhibitory effect towards the adjuvant. Despite 
this dampening, however, we did observe that when immune lymphocytes from 
cyclophosphamide-pretreated donors were transferred into naive recipients that 
were  later  immunized to  produce  disease,  an  antiidiotypic  immune response 
appeared and disease did not develop. This finding demonstrates that idiotype- 
reactive lymphocytes (perhaps T  cells; see Table II), unencumbered by nonspe- 
cific suppressor cells,  seem to induce a  suppressive antiidiotypic effect on the 
development of disease. 
Summary 
Antiidiotypic  immunity  can  successfully  inhibit  the  development  of  anti- 
tubular basement membrane (aTBM) disease that produces interstitial nephritis. 
Rats  normally  immunized  to  produce  disease,  however,  do  not  develop  this 1024  ANTIIDIOTYPIC IMMUNITY  IN  INTERSTITIAL NEPHRITIS 
regulatory and protective antiidiotypic effect. The failure to see such a regulatory 
response is functionally related to the influence of a nonspecific, RT7.1 +, OX8- 
suppressor T  cell that appears shortly after immunization. While this suppressor 
cell system can partially reduce the intensity of disease,  it also limits the host's 
ability to specifically regulate the aTBM immune response and, hypothetically, 
leaves the disease process in an operationally active mode. 
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